The purpose of this webinar is to present strategies to approach patient and family communication near the end-of-life in the setting of advanced liver disease with a focus on issues related to equity, diversity and inclusion. Patients with advanced liver disease experience high symptom burden, emotional distress, and prognostic uncertainty which makes them particularly vulnerable to suboptimal end-of-life care.

Amar Gupta, Giuliano Testa – 29 September 2021

Jie‐Lei Zhang, Bin‐Bin Du, Dian‐Hong Zhang, Huan Li, Ling‐Yao Kong, Guang‐Jian Fan, Ya‐Peng Li, Peng‐Cheng Li, Cui Liang, Zheng Wang, Lu‐Lu Yang, Zheng‐Yang Hao, Lei‐Ming Wu, Zhen Huang, Jian‐Zeng Dong, Jin‐Ying Zhang, Rui Yao, Shou‐Jun Wang, Yan‐Zhou Zhang – 29 September 2021

The Non-alcoholic steatohepatitis (NASH) Congressional briefing co-led by The American Association for the Study of Liver Diseases (AASLD) and Global Liver Institute (GLI) focused on establishing a national strategy to advance prevention, treatment, and diagnosis of NASH, the most severe form of nonalcoholic fatty liver disease.

Jason P. Cooper, James D. Perkins, Paul R. Warner, Alexandra Shingina, Scott W. Biggins, Janis L. Abkowitz, Jorge D. Reyes – 28 September 2021 – Acute graft‐versus‐host disease (GVHD) is a rare complication after orthotopic liver transplantation (OLT) that carries high mortality. We hypothesized that machine‐learning algorithms to predict rare events would identify patients at high risk for developing GVHD.

Yuan Fang, Yizhi Zhan, Yuwen Xie, Shisuo Du, Yuhan Chen, Zhaochong Zeng, Yaowei Zhang, Keli Chen, Yongjia Wang, Li Liang, Yi Ding, Dehua Wu – 27 September 2021

Xueyu Wang, Zhiqiang Wei, Bin Cheng, Jia Li, Yulin He, Tingyu Lan, Thekla Kemper, Yong Lin, Bin Jiang, Yongfang Jiang, Zhongji Meng, Mengji Lu – 27 September 2021

Lena Stockhoff, Theresa Muellner‐Bucsics, Antoaneta A. Markova, Marie Schultalbers, Simone A. Keimburg, Tammo L. Tergast, Jan B. Hinrichs, Nicolas Simon, Svetlana Gerbel, Michael P. Manns, Mattias Mandorfer, Markus Cornberg, Bernhard C. Meyer, Heiner Wedemeyer, Thomas Reiberger, Benjamin Maasoumy – 27 September 2021 – Transjugular intrahepatic portosystemic shunt (TIPS) is an effective treatment for portal hypertension‐related complications. However, careful selection of patients is crucial.

Makiko Urabe, Hayato Hikita, Yoshinobu Saito, Shinnosuke Kudo, Kenji Fukumoto, Naoki Mizutani, Yuta Myojin, Akira Doi, Katsuhiko Sato, Sadatsugu Sakane, Yuki Makino, Takahiro Kodama, Ryotaro Sakamori, Tomohide Tatsumi, Tetsuo Takehara – 27 September 2021 – Radiation therapy is one of the treatment methods for hepatocellular carcinoma. However, radiation tolerance of the liver is low, and the detailed effect of radiation on liver regeneration has not been clarified.

Hao Li, Gan Liu, Xiaoqing Wan, Luting Zhou, Zhen‐Bang Qin, Xian‐Hua Ma, Kai Su, Ya‐Jin Liu, Jinghao Yuan, Chun‐Chun Wei, An‐Jing Ren, Yu‐Xia Chen, Stephen G. Young, Hai Zhang, Zhifang Xie, Weiping J. Zhang – 27 September 2021